Syringeable Self-Organizing Gels that Trigger Gold Nanoparticle Formation for Localized Thermal Ablation.

gold reduction in situ gelling systems irradiation cycles localized heating effect photo-thermal therapy syringeable implant

Journal

Pharmaceutics
ISSN: 1999-4923
Titre abrégé: Pharmaceutics
Pays: Switzerland
ID NLM: 101534003

Informations de publication

Date de publication:
26 Jan 2019
Historique:
received: 01 01 2019
revised: 17 01 2019
accepted: 22 01 2019
entrez: 30 1 2019
pubmed: 30 1 2019
medline: 30 1 2019
Statut: epublish

Résumé

Block copolymer dispersions that form gels at body temperature and that additionally are able to reduce a gold salt to nanoparticles (AuNPs) directly in the final formulation under mild conditions were designed as hybrid depots for photothermal therapy. The in situ gelling systems may retain AuNPs in the application zone for a long time so that localized elevations of temperature can be achieved each time the zone is irradiated. To carry out the work, dispersions were prepared covering a wide range of poloxamine Tetronic 1307:gold salt molar ratios in NaCl media (also varying from pure water to hypertonic solution). Even at copolymer concentrations well above the critical micelle concentration, the reducing power of the copolymer was maintained, and AuNPs were formed in few hours without extra additives. Varying the copolymer and NaCl concentrations allowed a fine tuning of nanoparticles' shape from spherical to triangular nanoplates, which determined that the surface plasmon resonance showed a maximum intensity at 540 nm or at 1000 nm, respectively. The information gathered on the effects of (i) the poloxamine concentration on AuNPs' size and shape under isotonic conditions, (ii) the AuNPs on the temperature-induced gelling transition, and (iii) the gel properties on the photothermal responsiveness of the AuNPs during successive irradiation cycles may help the rational design of one-pot gels with built-in temperature and light responsiveness.

Identifiants

pubmed: 30691114
pii: pharmaceutics11020052
doi: 10.3390/pharmaceutics11020052
pmc: PMC6410185
pii:
doi:

Types de publication

Journal Article

Langues

eng

Subventions

Organisme : Ministerio de Economía y Competitividad
ID : SAF2017-83118-R
Organisme : Ministerio de Economía y Competitividad
ID : MAT2016-80266-R
Organisme : Xunta de Galicia
ID : Grupo de Referencia Competitiva ED431C 2016/008
Organisme : Xunta de Galicia
ID : Agrupación Estratégica en Materiales-AEMAT ED431E 2018/08
Organisme : European Regional Development Fund
ID : FEDER
Organisme : Agencia Estatal de Investigación
ID : AEI

Références

J Biomed Nanotechnol. 2014 Jun;10(6):959-69
pubmed: 24749391
Langmuir. 2008 Oct 7;24(19):10688-97
pubmed: 18785722
ACS Appl Mater Interfaces. 2014;6(21):18930-7
pubmed: 25286378
Nanoscale Res Lett. 2018 Sep 29;13(1):304
pubmed: 30269179
Mol Pharm. 2013 Mar 4;10(3):831-47
pubmed: 23360440
J Phys Chem B. 2010 Jan 14;114(1):66-76
pubmed: 19968275
Polymers (Basel). 2018 Jan 15;10(1):
pubmed: 30966111
Colloids Surf B Biointerfaces. 2015 Sep 1;133:270-7
pubmed: 26115534
Nanomedicine. 2013 Feb;9(2):257-63
pubmed: 22772047
Colloids Surf B Biointerfaces. 2018 Nov 1;171:176-185
pubmed: 30031302
J R Soc Interface. 2012 Sep 7;9(74):2059-69
pubmed: 22491977
Expert Opin Drug Deliv. 2016 Aug;13(8):1109-19
pubmed: 27074830
Sci Rep. 2014 Jul 07;4:5593
pubmed: 24998932
Proc Natl Acad Sci U S A. 2010 Jan 19;107(3):1235-40
pubmed: 20080552
J Colloid Interface Sci. 2018 Aug 15;524:42-51
pubmed: 29631218
ACS Appl Mater Interfaces. 2017 Mar 29;9(12):10453-10460
pubmed: 28271705
Acc Chem Res. 2011 Oct 18;44(10):947-56
pubmed: 21848277
J Phys Chem B. 2013 Mar 14;117(10):3028-39
pubmed: 23458728
J Phys Chem B. 2005 Apr 28;109(16):7766-77
pubmed: 16851902
Int J Pharm. 2016 Dec 30;515(1-2):729-739
pubmed: 27818245
ACS Appl Mater Interfaces. 2016 Aug 17;8(32):20600-13
pubmed: 27404480
J Colloid Interface Sci. 2000 Feb 15;222(2):213-220
pubmed: 10662516
J Nanopart Res. 2017;19(10):327
pubmed: 29026343
Int J Pharm. 2015 Oct 15;494(1):453-62
pubmed: 26315124
Eur Cell Mater. 2011 Apr 11;21:317-40
pubmed: 21484703
Int J Pharm. 2015 Jul 25;490(1-2):308-15
pubmed: 26027488
J Nucl Med. 2016 Jun;57(6):936-42
pubmed: 26848176
Nanoscale. 2014 Aug 21;6(16):9494-530
pubmed: 25030381
Chem Commun (Camb). 2014 Nov 28;50(92):14345-8
pubmed: 25286834
Proc Natl Acad Sci U S A. 2003 Nov 11;100(23):13549-54
pubmed: 14597719
Nanomedicine. 2014 Nov;10(8):1757-66
pubmed: 24941462

Auteurs

Sonia Cabana-Montenegro (S)

Departamento de Farmacología, Farmacia y Tecnología Farmacéutica, R+D Pharma Group (GI-1645), Facultad de Farmacia and Health Research Institute of Santiago de Compostela (IDIS), Universidade de Santiago de Compostela, 15782 Santiago de Compostela, Spain. scabmon@gmail.com.

Silvia Barbosa (S)

Área de Física de la Materia Condensada, Facultad de Física, Universidade de Santiago de Compostela, 15782 Santiago de Compostela, Spain. silvia.barbosa@usc.es.

Pablo Taboada (P)

Área de Física de la Materia Condensada, Facultad de Física, Universidade de Santiago de Compostela, 15782 Santiago de Compostela, Spain. pablo.taboada@usc.es.

Angel Concheiro (A)

Departamento de Farmacología, Farmacia y Tecnología Farmacéutica, R+D Pharma Group (GI-1645), Facultad de Farmacia and Health Research Institute of Santiago de Compostela (IDIS), Universidade de Santiago de Compostela, 15782 Santiago de Compostela, Spain. angel.concheiro@usc.es.

Carmen Alvarez-Lorenzo (C)

Departamento de Farmacología, Farmacia y Tecnología Farmacéutica, R+D Pharma Group (GI-1645), Facultad de Farmacia and Health Research Institute of Santiago de Compostela (IDIS), Universidade de Santiago de Compostela, 15782 Santiago de Compostela, Spain. carmen.alvarez.lorenzo@usc.es.

Classifications MeSH